Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
Latest press releases and news stories
Go to news archive
Featured News Article


18/06/2025
Press release
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years

17/06/2025
Press release
Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

06/06/2025
Press release
RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years

06/06/2025
News story
Revolutionizing Atopic Dermatitis 2025 Conference: Galderma’s Scientific Presentations

05/06/2025
News story
International Congress of Dermatology 2025: Galderma’s Scientific Presentations

28/05/2025
Press release
Galderma buys back shares worth CHF 233 million in the context of accelerated bookbuild offering
Galderma Annual Reports